[Hyperuricemia and gout : New aspects of an old disease].
Gouty arthritis is one of the most common arthritides. Due to increasing life expectancy and changing life style, a rising incidence and prevalence of gout can be expected. Because of associations with the diseases metabolic syndrome and cardiovascular morbidity, gout patients often suffer from significant morbidity. Besides the consequent usage of conventional therapeutics, new treatments for gout attacks and for lowering urate levels are available even for patients refractory to conventional therapy.
Rheumazentrum Bad Aibling-Erding, Gestütring 19, 85435, Erding, Deutschland. witt@rz-bae.de.
M
M
Witt
Rheumaeinheit, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, München, Deutschland.
H
H
Schulze-Koops
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D015210:Arthritis, Gouty / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D003937:Diagnosis, Differential; D019317:Evidence-Based Medicine; D006074:Gout Suppressants / Q000008:administration & dosage*; D006801:Humans; D033461:Hyperuricemia / Q000175:diagnosis* / Q000188:drug therapy*; D015900:Radiography, Dual-Energy Scanned Projection / Q000379:methods; D013864:Thioglycolates / Q000008:administration & dosage; D016896:Treatment Outcome; D014230:Triazoles / Q000008:administration & dosage; D014528:Uricosuric Agents / Q000008:administration & dosage
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D006074:Gout Suppressants; D013864:Thioglycolates; D014230:Triazoles; D014528:Uricosuric Agents; C000593471:lesinurad; C541220:canakinumab
Anakinra; Canakinumab; Computed X ray tomography, dual energy; Epidemiology, gout; Lesinurad